Evidence map›Paper›PMID 42548579›Full record

ArticleFrontiers in immunology2026

Pneumococcal transmission is driven by TNFR2+ regulatory T-cells.

Daan Beentjes, James Murray, Neil French, Caroline Vipond, Rong Xu, Aras Kadioglu

Abstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Daan BeentjesDepartment of Clinical Infection, Microbiology and Immunology, University of Liverpool, Liverpool, United Kingdom.
James MurrayDepartment of Clinical Infection, Microbiology and Immunology, University of Liverpool, Liverpool, United Kingdom.
Neil FrenchDepartment of Clinical Infection, Microbiology and Immunology, University of Liverpool, Liverpool, United Kingdom.
Caroline VipondVaccines, Science Research & Innovation, Medicines and Healthcare Products Regulatory Agency, Potters Bar, United Kingdom.
Rong XuDepartment of Clinical Infection, Microbiology and Immunology, University of Liverpool, Liverpool, United Kingdom.
Aras KadiogluDepartment of Clinical Infection, Microbiology and Immunology, University of Liverpool, Liverpool, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Pneumococcal serotype 1 (sequence type 217) is a leading cause of invasive disease outbreaks in Sub-Saharan Africa, causing significant morbidity and mortality. Understanding the transmission dynamics of hypervirulent strains such as ST217 is key to developing therapies and vaccines that can reduce outbreak incidence. Methods: The transmission dynamics of ST217 were investigated using an adolescent mouse pneumococcal transmission model, representing the population mainly affected by disease outbreaks in Sub-Saharan Africa. Results: We found that TNF receptor-2 (TNFR2)-positive regulatory T-cells (Tregs) paradoxically create the conditions that promote ST217 transmission. During ST217 colonisation, TNFR2 Conclusion: This study demonstrates an unexpected but key role of TNFR2

Indexed as

Pneumococcal InfectionsReceptors, Tumor Necrosis Factor, Type IIStreptococcus pneumoniaeT-Lymphocytes, RegulatoryAnimalsBacterial ProteinsDisease Models, AnimalFemaleMiceNasopharynxStreptolysinsTh17 CellsBacterial ProteinsplY protein, Streptococcus pneumoniaeReceptors, Tumor Necrosis Factor, Type IIStreptolysinsTnfrsf1b protein, mousecarriagepneumococcus (Streptococcus pneumoniae)regulatory T (Treg) cellTNFR2transmission

Identifiers

PMID42548579
PMCPMC13429388

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.